Is pharma willing to disrupt itself?  What does disruption look like in pharma?  If a change is good for everyone, is it really disruptive?  These and other questions were explored during the 2 day Disruptive Innovations to Advance Clinical Trials Conference in Boston last month.

See on portal.lillycoi.com